<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2014, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 29 Dec 2009 17:04:26 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>VIA Pharmaceuticals (VIAP) To Be Delisted January 4, 2010; Expects To Be Eligible For OTC Bulletin Board </title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+To+Be+Delisted+January+4%2C+2010%3B+Expects+To+Be+Eligible+For+OTC+Bulletin+Board+/5210428.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+To+Be+Delisted+January+4%2C+2010%3B+Expects+To+Be+Eligible+For+OTC+Bulletin+Board+/5210428.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+To+Be+Delisted+January+4%2C+2010%3B+Expects+To+Be+Eligible+For+OTC+Bulletin+Board+/5210428.html</guid>
   <pubDate>Tue, 29 Dec 2009 17:04:26 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals, Inc. (VIAP) Receives Non-Compliance Notification From NASDAQ</title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals%2C+Inc.+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4974963.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals%2C+Inc.+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4974963.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals%2C+Inc.+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4974963.html</guid>
   <pubDate>Mon, 28 Sep 2009 16:04:16 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Receives Non-Compliance Notification From NASDAQ</title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4955625.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4955625.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Receives+Non-Compliance+Notification+From+NASDAQ/4955625.html</guid>
   <pubDate>Fri, 18 Sep 2009 14:25:06 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients </title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html</guid>
   <pubDate>Fri, 01 May 2009 10:55:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients </title>
   <link>http://www.streetinsider.com/FDA/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Phase+2+Results+of+VIA-2291+in+Cardiovascular+Patients+/4606864.html</guid>
   <pubDate>Fri, 01 May 2009 10:55:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Announces License Agreement with Roche</title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+License+Agreement+with+Roche/4259252.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+License+Agreement+with+Roche/4259252.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+License+Agreement+with+Roche/4259252.html</guid>
   <pubDate>Tue, 23 Dec 2008 08:37:22 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Announces Positive Safety Results for Phase 2 Clinical Program of VIA-2291 </title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Safety+Results+for+Phase+2+Clinical+Program+of+VIA-2291+/3520469.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Safety+Results+for+Phase+2+Clinical+Program+of+VIA-2291+/3520469.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Announces+Positive+Safety+Results+for+Phase+2+Clinical+Program+of+VIA-2291+/3520469.html</guid>
   <pubDate>Fri, 04 Apr 2008 08:34:26 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>Rodman &amp; Renshaw Initiates Coverage on VIA Pharmaceuticals (VIAP) with a Market Outperform</title>
   <link>http://www.streetinsider.com/New+Coverage/Rodman+%26+Renshaw+Initiates+Coverage+on+VIA+Pharmaceuticals+%28VIAP%29+with+a+Market+Outperform/3152550.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Rodman+%26+Renshaw+Initiates+Coverage+on+VIA+Pharmaceuticals+%28VIAP%29+with+a+Market+Outperform/3152550.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Rodman+%26+Renshaw+Initiates+Coverage+on+VIA+Pharmaceuticals+%28VIAP%29+with+a+Market+Outperform/3152550.html</guid>
   <pubDate>Tue, 27 Nov 2007 08:53:28 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>ThinkEquity Starts VIA Pharmaceuticals (VIAP) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/ThinkEquity+Starts+VIA+Pharmaceuticals+%28VIAP%29+at+Buy/2950201.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/ThinkEquity+Starts+VIA+Pharmaceuticals+%28VIAP%29+at+Buy/2950201.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/ThinkEquity+Starts+VIA+Pharmaceuticals+%28VIAP%29+at+Buy/2950201.html</guid>
   <pubDate>Thu, 13 Sep 2007 12:08:10 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
  <item>
   <title>VIA Pharmaceuticals (VIAP) Approved for NASDAQ Listing</title>
   <link>http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Approved+for+NASDAQ+Listing/2710091.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Approved+for+NASDAQ+Listing/2710091.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/VIA+Pharmaceuticals+%28VIAP%29+Approved+for+NASDAQ+Listing/2710091.html</guid>
   <pubDate>Fri, 20 Jul 2007 16:10:09 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VIAP</category>
   	  </item>
 </channel>
</rss>
